Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression

E. Negredo, L. Cruz, R. Paredes, L. Ruiz, C.R. Fumaz, A. Bonjoch, S. Gel, M. Tuldrà, M. Balagué, S. Johnston, A. Arnó, A. Jou, C. Tural, G. Sirera, J. Romeu, B. Clotet

Research output: Contribution to journalArticleResearch

161 Citations (Scopus)
Original languageEnglish
Pages (from-to)504-510
JournalClinical Infectious Diseases
Issue number4
Publication statusPublished - 1 Jan 2002

Cite this